Michael H. Kagey

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)”.

A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)

Prostate Cancer and Prostatic Diseases(2024)10.1038/s41391-024-00798-z

N/A

0DataRank · unranked

9 citations

Russell K. Pachynski, Samuel R. Denmeade, Rahul Aggarwal, Jiehui Deng, Victor Adorno Febles +27 more

Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab

medRxiv(2024)10.1101/2024.10.08.24315092

N/A

0DataRank · unranked

3 citations

Milan Parikh, Leon Pappas, Moshe Sade-Feldman, Anupriya S. Kulkarni, Lynn Bi +19 more